2023年5月4日

回家睡眠测试公司的目标是在五年内将增长10倍。总经理迈克尔Barbella Editor05.04.23日出已收到€1700万资金注入进去合作伙伴和欧洲创新委员会领导的共同基金)。创业公司还获得了在欧洲和美国监管机构的批准。”这一最新融资操作,连同我们的认证,证实了我们的雄心改善治疗全球10亿人患有睡眠呼吸暂停,“日出CEO Laurent Martinot说。“研究表明绝大多数的这些人没有意识到这种疾病。睡眠呼吸暂停症可能是最常见的一种慢性疾病和诊断不足。“新融资证实其历史投资者的信心,韦弗斯IUF和那慕尔投资。新投资者,如Sambrinvest IMBC, InvestBW Sofinex,共同基金现在加入日出。最新的资金增加了€1200万日出引起了自成立以来。启动希望加快其增长在未来几个月有两个重大举措:商业化的技术在美国和招聘新人才。 Sunrise aims to multiply the size of its teams by 10-fold in the next five years. “The EIC Fund has established itself as a strong force in EU deep-tech investments. This unique form of financing via EIC—combining grants and equity—is proving itself highly attractive to Europe's most promising startups, and providing them with the means to develop and scale their businesses in Europe,” EIC Fund Board Member Hermann Hauser stated. Sunrise has received U.S. Food and Drug Administration and MDR approval of its second-generation technology. The company has also been awarded the SleepTech Award 2022 by the American National Sleep Foundation. "Sunrise's solutions will change the lives of millions of people around the world who suffer from sleep disorders today. Their clinical performance technology is the first to provide patients with a simple, accessible and uniquely accurate sleep analysis solution,” said Philippe Peltier, a partner at Kurma Partners. Launched in 2015, Sunrise currently employs about 30 people. The firm's artificial intelligence-powered technology analyzes a new signal on the human body, jaw movements, and other common apnoea signals, from a single sensor simply placed on the chin. Kurma Partners is a player in healthcare and biotechnology funding across Europe. The venture capital group invests in high-potential companies and startups to support their development. Kurma Partners' aims to contribute to innovative solutions for diagnosing and treating serious diseases. The European Innovation Council Fund from the European Commission is an agnostic fund: it invests across all technologies and verticals, and all EU countries and countries associated to Horizon Europe. It provides the investment component of the EIC Accelerator blended finance. The main purpose of EIC Fund is to support companies in the development and commercialisation of disruptive technologies, bridging with and crowding in market players, and further sharing risk by building a large network of capital providers and strategic partners suitable for co-investments and follow-on funding. The Fund pays particular attention to the empowerment and support of female founders as well as the ambition to reduce the innovation divide among EU countries. The VIVES Inter University Fund was created in 2020 on the initiative of the UCLouvain. It aims to invest in projects with a positive impact on society and to support companies at different stages of their development. Through its partnerships, VIVES IUF relies on a network of multi-sectoral experts to strengthen the development of high-quality innovations. Trending